Rheumatology research in China
Peking University ranks first in China for Rheumatology research in 2022-now (#5 worldwide), followed by Shanghai Jiao Tong University and Sichuan University.
- China's world rank
- #2 of 50 countries, 2022-now
- Works, 2022-now
- 15k
- Top-10% rate
- 14.7%
- Ranked institutions
- 53
This ranks research output and citation impact, not the quality of diagnosis, treatment or care.
What is the best university for Rheumatology in China?
Institutions in China above the floor of 40 fractional works in Rheumatology, ordered by their worldwide rank on research quality, 2022-now.
Who are the top Rheumatology researchers in China?
Qing Yan Jiang, Nan Shen and Chi Chiu Mok rank highest among researchers based in China, on their papers in Rheumatology that reached the world top 10%, beyond the 10% expected.
- 1Qing Yan Jiang#89,731 worldwide overall22.8 of 51 papers here in the top 10%
- 2Nan Shen#70,312 worldwide overall21.5 of 52 papers here in the top 10%
- 3Chi Chiu Mok#143,028 worldwide overall25.6 of 95 papers here in the top 10%
- 4Xiaofeng Zeng#408,788 worldwide overall27.8 of 136 papers here in the top 10%
- 5Quanyi Guo#27,863 worldwide overall16.1 of 28 papers here in the top 10%
- 6Xuan Zhang#269,733 worldwide overall20.8 of 76 papers here in the top 10%
- 7Shuyun Liu#38,071 worldwide overall15.7 of 28 papers here in the top 10%
- 8Chak Sing Lau#362,769 worldwide overall24.2 of 117 papers here in the top 10%
- 9Wenguo Cui#2,777 worldwide overall14.5 of 23 papers here in the top 10%
- 10Zhaohua Zhu#244,648 worldwide overall17.6 of 54 papers here in the top 10%
- 11Jiacan Su#6,632 worldwide overall14.8 of 27 papers here in the top 10%
- 12Zhanguo Li#781,490 worldwide overall21.9 of 104 papers here in the top 10%
- 13Lai‐Shan Tam#286,125 worldwide overall23.2 of 120 papers here in the top 10%
- 14Tak Mao Chan#730,480 worldwide overall18.5 of 80 papers here in the top 10%
- 15Xingdong Zhang#24,711 worldwide overall13.4 of 32 papers here in the top 10%
Ranked among researchers based in China on their work in Rheumatology alone: how many more of their papers here reached the world top 10% for their subfield and year than the 10% expected.